1. KD Tripathi MD. Cholinergic system and drugs. Essentials of Medical Pharmacology 7th ed. New Delhi, May 2013. Page - 109.
2. Achilles J. Pappano. Cholinoceptor-Activating & cholinesterase-Inhibiting drugs. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. Page - 119.
3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 1172-1173.
4. Lorenzo Maggi & Renato Mantegazz. Treatment of Myasthenia Gravis Focus on Pyridostigmine: Clinical drug investigation, Aug 2011; [Accessed Oct 8, 2020] https://www.researchgate.net/publication/51546334_Treatment_of_Myasthenia_Gravis_Focus_on_Pyridostigmine
5. Mylan Products Ltd. Electronic Medicines Compendium (EMC); [Revised Feb 2018] [Accessed Oct 8, 2020] https://www.medicines.org.uk/emc/files/pil.962.pdf
6. Amneal Pharmaceuticals Pvt. Ltd. April 24, 2003; [Revised Jan 2020] [Accessed Oct 8, 2020] https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f56facf-1f0a-4ba5-876d-757b114dfa45